本文へスキップ

相互作用

Imatinib + Lomitapide

重症度: 併用禁忌

Imatinib and Lomitapide: contraindicated interaction.

最終更新日

医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。

このページの臨床コンテンツは英語でのみ提供されています。

概要

Imatinib inhibits CYP3A4 and can substantially increase lomitapide exposure. This raises the risk of hepatotoxicity and gastrointestinal adverse effects. Lomitapide labeling contraindicates moderate and strong CYP3A4 inhibitors.

この相互作用をわかりやすく説明すると

Imatinib and Lomitapide are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Imatinib belongs to Oncology; Lomitapide belongs to Cardiovascular.

エビデンスレベル: Moderate

なぜ起こるのか

Imatinib inhibits CYP3A4, the main pathway of lomitapide metabolism, increasing its plasma concentrations.

対処法

Do not coadminister. Use an alternative lipid-lowering strategy while imatinib is required, or interrupt lomitapide if imatinib is unavoidable and follow labeling.

薬剤師に尋ねること

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+会員向け

ページ全体を見る

アカウントを作成してPro+トライアルを始めると、ImatinibとLomitapideの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

WebでPro+を14日間無料でお試し。カード登録不要。

よくある質問

Can I take Imatinib with Lomitapide?

MediHelp rates the interaction as contraindicated. Imatinib and Lomitapide are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Imatinib inhibits CYP3A4 and can substantially increase lomitapide exposure. This raises the risk of hepatotoxicity and gastrointestinal adverse effects. Lomitapide labeling contraindicates moderate and strong CYP3A4 inhibitors.

How serious is the interaction between Imatinib and Lomitapide?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not coadminister. Use an alternative lipid-lowering strategy while imatinib is required, or interrupt lomitapide if imatinib is unavoidable and follow labeling.

What other medicines interact with Imatinib?

MediHelp also lists interactions of Imatinib with, for example, Lonafarnib, Amobarbital, Apalutamide. The full list is on the Imatinib page.

完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで

MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。

A–Zで探す · 相互作用

アプリを入手 ログイン